Quitting smoking is very difficult, and many times willpower alone is not enough to break the habit. Now that FDA has approved Chantix (Verinicline Tartrate) as a smoking cessation aid you won’t have to try and fail anymore. Unlike many other quit-smoking aids which are anti depressants, the active ingredient in Chantix, Verinicline Tartrate, works on the areas of the brain that are affected by nicotine. Chantix, which is a new molecule entity, acts at the sites of the brain that are affected by nicotine. By simulating the effects of nicotine on the brain, withdrawl symptoms are dramatically reduced.

Chantix also works by blocking the nicotine from entering relevant parts of the brain eliminating the reward that a smoker feels when they smoke, which may help to break the addiction if those who are trying to quit begin to smoke again. In clinical trials, it was shown that Chantrix was far superior to placebo in helping to quit. With 44% of participants in the Chantrix study group quitting after 4 weeks, compared to just 17% of the placebo group. The typical course of treatment with Chantix is 12 weeks, but users who have successfully quit can continue for a further 12 weeks to increase their chances of long term success. Smokers that are looking to quit have been given a new and effective tool to use. Chantix may just be exactly what you need to kick the habit permanently.